Vera Therapeutics (VERA) Capital Expenditures (2020 - 2026)
Vera Therapeutics (VERA) reported Capital Expenditures of $23000.0 for Q1 2026, down 87.7% on a YoY basis from $187000.0 in Q1 2025, and down 77.45% quarter-over-quarter from $102000.0 in Q4 2025.
Vera Therapeutics (VERA) Capital Expenditures (2020 - 2026) Analysis & Trends
Vera Therapeutics has reported Capital Expenditures for 6 years, with the latest figure at $23000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 87.7% year-over-year to $23000.0; the trailing twelve-month figure through Mar 2026 stood at $466000.0 (down 59.79% YoY), and the FY2025 full-year result was $630000.0, down 35.19% from the prior year.
- Capital Expenditures for Q1 2026 stood at $23000.0, down from $102000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $645000.0 in Q4 2024, with the low at $6000.0 in Q2 2022.
- Historically, Capital Expenditures has averaged $145833.3 across 5 years, with a median of $95500.0 in 2024.
- Annual changes were most pronounced in 2024 — Capital Expenditures jumped 923.81% — and 2026, when it tumbled 87.7%.
- Vera Therapeutics' Capital Expenditures stood at $38000.0 in 2022, then jumped by 65.79% to $63000.0 in 2023, then jumped by 923.81% to $645000.0 in 2024, then tumbled by 84.19% to $102000.0 in 2025, then sank by 77.45% to $23000.0 in 2026.
- The last three Capital Expenditures figures came in at $23000.0 (Q1 2026), $102000.0 (Q4 2025), and $133000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Vera Therapeutics | 2.51 Bn | 1.91 Bn | - | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 645,000.00 |
| Dec 31, 2024 | 645,000.00 |
| Sep 30, 2024 | 238,000.00 |
| Sep 30, 2024 | 238,000.00 |
| Jun 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 89,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2022 | 38,000.00 |
| Sep 30, 2022 | 38,000.00 |